WebBruce Jacobs, CFA, MBA Chief Financial Officer [email protected] Christopher F. Brinzey Westwicke, an ICR Company for Kymera Therapeutics … WebJul 8, 2024 · WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Leigh Morgan to its Board of Directors.Ms. Morgan …
Kymera Therapeutics Appoints Elena Ridloff, CFA, to Board of …
WebSteve Hall is a Board Member at Kymera Therapeutics. He brings more than 25 years of pharmaceutical experience from both multinational pharmaceutical companies and biotech organizations to Lilly Ventures. Prior to joining Lilly Ventures, Steve was Senior Vice President, Research and Development, at Serenex, Inc. where he was also a co-founder. … WebDirector, Proteomics. Jun 2024 - Jul 20242 years 2 months. Cambridge, Massachusetts, United States. • Instrumental in providing strategic and … creating your own business card in outlook
Kymera Therapeutics Strengthens Board of Directors with …
WebWalker is on the board of directors of Aldeyra Therapeutics, Inc., a publicly held biotechnology company, as well as several private companies. In 2016, Dr. Walker was awarded the Frank Baldino Bioscience CEO of the Year award and the Ernst & Young Entrepreneur of the Year Greater Philadelphia award. He is a Fellow of the American … WebJan 18, 2024 · Dr. Maraganore joins Kymera’s Board after having led Alnylam Pharmaceuticals as founding CEO and Director and transformed the field of RNA therapeutics for the last nearly 20 years. “John... WebMar 16, 2024 · Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Elena Ridloff, CFA, to its Board of Directors, where she will serve as Chair of the Audit Committee dobyns fury 733c